At a glance
- What the study gets you
- Health checks and monitoring — no treatment given
- Type of study
- Observational (no treatment given)
- Time in hospital
- In-person visits at study sites — visit count not specified by the sponsor
- Drug or intervention
- Not specified by the sponsor
- How long the study runs
- Study runs about 120 months (dates as stated)
- About the drug or intervention
- Not specified by the sponsor
- Patient visit burden
- Not specified by the sponsor
- Type of study
- Observing health over time
- Ages
- 16 Years to 99 Years
- Who
- All
- Number of participants
- 4,000
- Started
- 2021-09-17
- Last checked
- 2024-11
Plain English Summary
What is this study?
- • Testing a new treatment for inflammatory bowel disease 1
- • Clinical study - 4,000 participants
- • To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
Who can take part?
- • Ages 16 Years to 99 Years
- • Diagnosed with inflammatory bowel disease 1
Where?
- • Hull - Hull Royal Infirmary
This is a simplified summary. Always discuss with your doctor before making any decisions.
About This Trial
To develop and train a convolutional neural network to detect and characterize disease severity of inflammatory bowel disease during endoscopy
More detail
To develop and train a Convolutional Neural Network to detect and characterize disease severity in inflammatory bowel disease during endoscopy. This initiative will inevitably establish a high-quality large image database. Our secondary study aims are therefore to use the images we collect to advance the field of deep learning and computer aided diagnosis in inflammatory bowel disease by establishing an image database. This will involve developing a framework combining deep learning and computer vision algorithms. The ultimate aim is to use the image database to produce high impact research outcomes and training resources leading to an improvement in the quality of endoscopy performed, reduce inter-observer variability in disease assessment and a reduction in missed bowel cancer rates and associated mortality.
How this trial compares with your answers
Answer 2 more questions to improve match
What we know so far
Still need:
- • Tell us your age for better matching
- • Tell us your sex for better matching
Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.
Eligibility at a Glance
Key info
- Age: 16 Years - 99 Years
- Who can join: All genders
What the study is looking for
- ✓• Any adult patient aged 16 years or older who has consented to undergo endoscopic investigation where images are...
Who cannot take part
- ✗• Any patient under the age of 16
- ✗Patients who are unable to give agreement to take part to undergo endoscopic investigation or those who do not wish their...
See the full criteria
Where Is This Study? (1 UK site)
Hull Royal Infirmary
Hull HU3 2JZ, United Kingdom
James Illingworth
hyp-tr.development.research@nhs.net01482 461883 or 461903How to Get in Touch
Shaji Sebastian
Sponsor contactCONTACT
Laurence Lovat
Sponsor contactCONTACT